» Articles » PMID: 35958295

Predictors of Stent Restenosis in Han and Uygur Patients with Coronary Heart Disease After PCI in the Xinjiang Region

Overview
Publisher Wiley
Date 2022 Aug 12
PMID 35958295
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Stent restenosis after PCI seriously affects the efficacy and prognosis; therefore, the study of ISR risk factors has become an urgent topic to be solved.

Objective: To investigate the risk factors for in-stent restenosis (ISR) after percutaneous coronary intervention (PCI) in Han and Uygur patients with coronary heart disease.

Methods: The clinical data of 345 Han and 127 Uygur patients who underwent intracoronary stent implantation were divided into an ISR group and a non-ISR group. The general clinical data, laboratory indicators, and coronary artery lesions were compared.

Results: Age (OR = 1.040, 95% CI: 1.006∼1.075), triglycerides (OR = 1.440, 95% CI: 1.050∼1.973), total cholesterol (OR = 5.256, 95% CI: 2.826∼9.773), and ApoB (OR = 137.540, 95% CI: 11.364∼899.455) were independent risk factors for ISR after PCI in the Han patients, while ApoAI (OR = 0.002, 95% CI: 0.001∼0.011), MCV (OR = 0.824, 95% CI: 0.744∼0.911), MCH (OR = 0.421, 95% CI: 0.324∼0.548), and MCHC (OR = 0.934, 95% CI: 0.903∼0.965) were protective factors of ISR after PCI in Han patients, and the logistic regression equation composed of various factors predicted that the area under the ROC curve of ISR was 0.905. ApoB (OR = 11.571, 95% CI: 1.667∼80.340), Gensini score (OR = 1.017, 95% CI: 1.003∼1.031), and diabetes history (OR = 3.474, 95% CI: 1.189∼10.151) were independent risk factors for ISR after PCI in Uygur patients, and the area under ROC curve of ISR predicted by logistic regression equation is 0.807. The predictive efficiency of the Gensini score and ApoB level for ISR in Uygur patients was higher than that in Han, while the predictive efficiency of levels of ApoAI and MCH for ISR in Han patients was higher than that in Uygur ( < 0.05).

Conclusion: The independent risk factors for ISR after PCI in Han and Uygur patients in Xinjiang are different.

Citing Articles

Comparison of Gensini score and SYNTAX score for predicting in-stent restenosis in patients with coronary artery disease and drug-eluting stent implantation.

Gai M, Yan S, Wang M, Ruze A, Zhao L, Li Q Sci Rep. 2025; 15(1):1077.

PMID: 39775185 PMC: 11706961. DOI: 10.1038/s41598-025-85191-z.


Risk prediction model for in-stent restenosis following PCI: a systematic review.

Xiang Q, Xiong X, Liu S, Zhang M, Li Y, Wang H Front Cardiovasc Med. 2024; 11:1445076.

PMID: 39267809 PMC: 11390508. DOI: 10.3389/fcvm.2024.1445076.


A systematic review and bioinformatic study on clinical, paraclinical, and genetic factors predisposing to stent restenosis following percutaneous coronary intervention.

Shahsanaei F, Gharibzadeh A, Behrooj S, Abbaszadeh S, Nourmohammadi M BMC Cardiovasc Disord. 2024; 24(1):304.

PMID: 38877398 PMC: 11177414. DOI: 10.1186/s12872-024-03955-3.

References
1.
Hee L, Terluk A, Thomas L, Hopkins A, Juergens C, Lo S . Late clinical outcomes for SeQuent please paclitaxel-coated balloons in PCI of instent restenosis and de novo lesions: A single-center, real world registry. Catheter Cardiovasc Interv. 2016; 89(3):375-382. DOI: 10.1002/ccd.26546. View

2.
Chen B, Liu J, Xing J, Liu H, Wei Y, Xue X . Analysis of the Correlation Between the Ratio of Monocytes to High-Density Lipoprotein Cholesterol and in-Stent Restenosis in Patients with Premature Coronary Heart Disease. Clin Appl Thromb Hemost. 2022; 28:10760296221079334. PMC: 8864282. DOI: 10.1177/10760296221079334. View

3.
Ullrich H, Olschewski M, Munzel T, Gori T . Coronary In-Stent Restenosis: Predictors and Treatment. Dtsch Arztebl Int. 2021; 118(38):637-644. PMC: 8715314. DOI: 10.3238/arztebl.m2021.0254. View

4.
Austen W, Edwards J, Frye R, Gensini G, Gott V, Griffith L . A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation. 1975; 51(4 Suppl):5-40. DOI: 10.1161/01.cir.51.4.5. View

5.
Welsh C, Celis-Morales C, Brown R, Mackay D, Lewsey J, Mark P . Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular Disease. Circulation. 2019; 140(7):542-552. PMC: 6693929. DOI: 10.1161/CIRCULATIONAHA.119.041149. View